Poulli, T.; Liaveri, P.; Liapis, G.; Daoudaki, M.; Fouza, A.; Stangou, M.; Moustakas, G.
Therapeutic Challenges and New Era in Fibrillary Glomerulonephritis with the Introduction of DNAJB9: Experience from a Tertiary Nephrology Center. J. Clin. Med. 2025, 14, 3709.
https://doi.org/10.3390/jcm14113709
AMA Style
Poulli T, Liaveri P, Liapis G, Daoudaki M, Fouza A, Stangou M, Moustakas G.
Therapeutic Challenges and New Era in Fibrillary Glomerulonephritis with the Introduction of DNAJB9: Experience from a Tertiary Nephrology Center. Journal of Clinical Medicine. 2025; 14(11):3709.
https://doi.org/10.3390/jcm14113709
Chicago/Turabian Style
Poulli, Tsielestina, Paraskevi Liaveri, George Liapis, Maria Daoudaki, Ariadni Fouza, Maria Stangou, and George Moustakas.
2025. "Therapeutic Challenges and New Era in Fibrillary Glomerulonephritis with the Introduction of DNAJB9: Experience from a Tertiary Nephrology Center" Journal of Clinical Medicine 14, no. 11: 3709.
https://doi.org/10.3390/jcm14113709
APA Style
Poulli, T., Liaveri, P., Liapis, G., Daoudaki, M., Fouza, A., Stangou, M., & Moustakas, G.
(2025). Therapeutic Challenges and New Era in Fibrillary Glomerulonephritis with the Introduction of DNAJB9: Experience from a Tertiary Nephrology Center. Journal of Clinical Medicine, 14(11), 3709.
https://doi.org/10.3390/jcm14113709
